Skip to content

We discover biomarkers and design companion diagnostics for immuno-oncology and cell therapies

We unlock the full potential of single-cell omics and unravel the complexity of cancer diseases

USZ Zurich
Inselspital
Geninus logo

The problem we are solving:

Precision biomarkers & companion diagnostics

Most drugs work only on a fraction of the patients, leading to high failure rates of clinical trials and poor efficacy of drugs when delivered to patients. This calls for precision medicine solutions that match the right patient to the right treatment. Combining deep molecular profiling and our unbiased and robust AI discovery platform ScaiVision leads to highly accurate biomarkers and clinically-relevant insights.

clinical trials

90% of clinical trials fail

50% of failed trials lack clinical efficacy

90 / 50

Actionable biomarkers

approved drugs

90% of approved drugs work only in

50% of the patients

What biomarkers are you looking for?

We discover clinically-relevant biomarkers with single-cell analytics and AI

Disease diagnosis​

Disease diagnosis

Identify novel biomarkers for an early disease diagnosis

Patient stratification​

Patient stratification

Identify patients with higher chance to respond to treatment

Mode of Action​

Mode of
Action

Understand the effect on patient’s immune response

Patient monitoring​

Patient monitoring

Identify prognostic and predictive biomarkers

12 successful discovery projects

1000+ single cell samples analyzed

50 Billion data points

We revolutionize biomarker discovery with AI and single-cell data

Single-cell resolution icon

Single-cell resolution

We harness the richness of single-cell multiomics data to explain complex biological processes

Artificial Intelligence Icon

Artificial Intelligence

We apply AI for unbiased, innovative, sensitive, and integrative multiomics data analysis

Biomarker discovery icon

Biomarker discovery

We deliver translatable biomarker signatures related to therapy response, diagnosis or disease severity

Gain superior speed, robustness, translatability, and unmatched discovery potential

Play Video about Scailyte's Strengths
Gain superior speed, robustness, translatability and unmatched discovery potential

Faster time-to-insights for accelerated biomarker discovery

Sensitive and specific biomarker discovery to identify clinical biomarkers not achievable by conventional analytics

Fully transparent and explainable results allow the translation of biomarker discoveries into simple, affordable clinical assays

Demonstrated best-in-class AI, ensuring superior robustness and reliability of biomarker discoveries

The discovery and development of biomarkers for precision medicine using single-cell data and AI fully exploits the power of cutting-edge technologies in translational research. We are paving the way for the development of new life-saving diagnostics and next-generation therapeutics for complex diseases.

Learn about our solutions for drug developers
Hemex

Partner Testimonials

Meghan Verschoor

Meghan Verschoor

Associate Director, Data Science in Clinical and Translational Medicine at Turnstone Biologics

“Our team is very impressed with the level of attention to detail and domain knowledge that the Scailyte team brings to our project. We’re excited to continue working with your team!”
Thomas Mehrling

Thomas Mehrling

MD PhD, CEO of MaxiVAX

“Scailyte has been instrumental in analyzing phase IIa clinical single-arm trial data of our most advanced development program. Scailyte’s scientific expertise, communication style and agility are commendable”
Prof. Dr Michael Mueller

Prof. Dr Michael Mueller

Leading Clinician in Women’s Health & Scientific Advisor

“Our current collaboration with Scailyte in the field of women’s health is a truly innovative approach. We are integrating cutting edge technologies to develop biomarkers that will be the basis for impactful diagnostic solutions.”
Pascal Koenig

Pascal Koenig

Entrepreneur & Chairman of the Board of Directors

“As the co-founder and former CEO of Ava Women, I have experienced the power that big datasets have on the healthcare industry. Scailyte’s mission, proven technology and strong expertise have convinced me to join the team. I am delighted to contribute and assist in bringing Scailyte’s solution to patients around the world.”

Recent News

Scailyte at BIO International Convention 2024

We are thrilled to attend the Bio International Convention 2024 in San Diego on June 3-6 where busin...

Read more

Recent News

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Recent News

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Recent News

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

Recent News

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

Recent News

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Recent News

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Recent News

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

Recent News

01 /04

Scailyte at BIO International Convention 2024

We are thrilled to attend the Bio International Convention 2024 in San Diego on June 3-6 where busin...

Read more

Inside Scailyte - Episode 10: Meet Dennis Göhlsdorf

In our latest episode of "Inside Scailyte," we're excited to introduce you to Dennis Göhlsdorf, our...

Read more

Recent News

02 /04

Precision Med TRI-CON 2024

Join us for our presentation on "Enabling Precision Medicine by Combining Single-Cell Multi-Omics Da...

Read more

Inside Scailyte - Episode 9: Meet Shaoline Sheppard

In the latest episode of "Inside Scailyte," we're thrilled to introduce you to Shaoline Sheppard, ou...

Read more

Recent News

03 /04

NextGen Omics US 2024

Scailyte is headed to NextGen Omics US 2024 in Boston, MA on March 21-22. Join us as we showcase our...

Read more

AI-driven single-cell data analysis identifies a cell signature predictive of neurotoxicity and clinical response in CAR-T cell therapy of DLBCL

In our latest white paper, "AI-driven single-cell data analysis identifies a cell signature predicti...

Read more

Recent News

04 /04

Inside Scailyte - Episode 8: Meet Sajid Maqbool

Meet Sajid Maqbool, our Information Technology Engineer at Scailyte AG. In our latest episode of "In...

Read more

Inside Scailyte – Episode 7: Meet Anna Dimitrova

Meet Anna Dimitrova, our Chief Financial Officer at Scailyte AG. In our latest episode of "Inside Sc...

Read more

Recent News